Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
VR1
AddedFeb 16, 2024
UpdatedJun 18, 2026
VR1

VR1

VR1 Corp: NY-based manufacturer of non-prescription migraine and severe headache treatments since 2012.

HQ
New York City, NY, US
Founded
2012
Overview
Compare
Fundraising
Employees

VR1 Corp, founded in 2012 and based in New York, develops and manufactures non-prescription medicines for treating migraines and severe headaches. The company focuses on providing effective, accessible solutions for individuals suffering from these debilitating conditions.

VR1's innovative approach has significantly impacted the non-prescription medicine market, offering relief to countless patients. Their commitment to quality and efficacy has positioned them as a trusted name in headache and migraine treatment.

VR1 - Similar Companies

AppliedVR logo

AppliedVR

appliedvr.io

VRstudios logo

VRstudios

RetinasVR logo

RetinasVR

The Virtual Reality Company logo

The Virtual Reality Company

thevrcompany.com

MyndVR logo

MyndVR

myndvr.com

KindVR logo

KindVR

kindvr.com

Envelop VR logo

Envelop VR

Exit Reality logo

Exit Reality

Wide Awake VR logo

Wide Awake VR

wideawakevr.com

Enhance-VR logo

Enhance-VR

Happinss logo

Happinss

VRenity logo

VRenity

vrenity.com

Ilivevr logo

Ilivevr

ZenVR logo

ZenVR

zenvrapp.com

VRmersive logo

VRmersive

VR1 - Quick Facts

Who are VR1's competitors?

Companies similar to VR1 include AppliedVR, VRstudios, RetinasVR and The Virtual Reality Company.

When was VR1 founded?

VR1 was founded in 2012.

Where is VR1's headquarters located?

VR1's headquarters is located in New York City, NY, US.

When was VR1's last funding round?

VR1's most recent funding round was for $900.3k (USD) in September 2014.

How much has VR1 raised to-date?

As of Sep 16, 2014, VR1 has raised a total of $2.4M (USD).

How many employees does VR1 have?

VR1 has 125 employees as of Feb 4, 2024.

VR1 - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Medicine
Tags
  • Software
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8731Commercial Physical and Biological Research